Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12091413 Inhibitors of NEK7 kinase

Patent 12091413 was granted and assigned to Halia Therapeutics, Inc. on September, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Halia Therapeutics, Inc.

0

Current Assignee

Halia Therapeutics, Inc.

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Alexis Henri Abel Mollard0

David James Bearss0

John Sai Keong Kauwe, III0

Date of Patent

September 17, 2024

0

Patent Application Number

183223800

Date Filed

May 23, 2023

0

Patent Citations

US Patent 10647680 Urea compound, preparation method therefor and medical use thereof

0

US Patent 11713321 Inhibitors of NEK7 kinase

0

US Patent 11161852 Inhibitors of NEK7 kinase

0

US Patent 7750160 Isoxazolyl urea derivatives as kinase modulators

0

US Patent 7863444 4-aminopyrrolopyrimidines as kinase inhibitors

0

US Patent 7947835 Certain substituted amides, method of making, and method of use thereof

0

US Patent 9464065 Compounds and methods for inducing chondrogenesis

0

US Patent 9580421 Urea derivatives and uses thereof

0

Patent Primary Examiner

Niloofar Rahmani

0

CPC Code

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12091413 Inhibitors of NEK7 kinase

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool